Gastroparesis-Pipeline Insights, 2015 - A DelveInsight’s Report

DelveInsight, the leading market research and consulting company has added a new report “Gastroparesis-Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.
By: DelveInsight Business Research
 
NEW DELHI - Oct. 12, 2015 - PRLog -- The report “Gastroparesis-Pipeline Insights, 2015” provides client with details on the ongoing enterprises and the upcoming business opportunities related to new interventions. It comprehensively includes:

  • The report gives information of around 15 pipeline drugs with 10+ companies involved in drug development. There are 2 drugs in Phase III, 5 in Phase II, 5 inactive and 2 discontinued drugs.

 • Metoclopramide Hydrochloride developed by Evoke Pharma and Etx 101 developed by ETX Pharma, Inc are under Phase III clinical trials.

•  R&D activities and technologies used along with the pipeline  molecules in     development

•  Stages of development of pipeline molecules.

• Therapeutic assessments by molecule types, route of administration, monotherapy and combination products.

• Information related to collaborations, in-licensing and out-licensing deals.

DelveInsight’s, “Gastroparesis-Pipeline Insights, 2015” report provides the in-depth analysis of the pipeline assets across the Gastroparesis. Therefore the report on “Gastroparesis-Pipeline Insights, 2015” provides information on chemical, technology information and comparative analysis at various stages. In addition, it helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight is offering the Report at a price of USD 1,250 as a single user license, USD 2,500 as a site license and USD 4,000 as a Global/Enterprise License.

For more information on Pipeline Insight Reports, email atinfo@delveInsight.com

Contact Us:

DelveInsight Business Research

New Delhi-110075, India

Phone: +91-11-45689769, +91 9650213330

Website: http://delveinsight.com

About Us

DelveInsight is a leading Business Consulting and Market Research Firm. They help clients to find answers relevant to their business, facilitating decision-making, identify potential market opportunities, competitor assessments and business environmental assessment. In addition to this DelveInsight also deals in providing custom research services in coherence with interest area of the clients.

Contact
DelveInsight Business Research
***@delveinsight.com
End
Source:DelveInsight Business Research
Email:***@delveinsight.com Email Verified
Tags:Gastroparesis, Etx 101, Metoclopramide Hydrochloride
Industry:Business
Location:New Delhi - Delhi - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: Oct 12, 2015
DelveInsight PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share